Clinical Trials Browser

Phase 2 × Thyroid Neoplasms × Axitinib × Clear all

NCT00389441 2013-11-25

Study Of AG-013736 In Patients With 131I-Refractory Thyroid Cancer

Phase 2 Completed

52 enrolled 9 charts

Carcinoma, Thyroid Neoplasms

NCT00094055 2012-06-26

Study of the Anti-angiogenesis Agent AG-013736 in Patients With Metastatic Thyroid Cancer

Phase 2 Completed

60 enrolled 9 charts

Thyroid Neoplasms